Powered by

-aTyr Pharma Announces Participation at March Investor Conferences

Mar 05, 2019 - ENP Newswire

SAN DIEGO - aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that management will provide an update on the ongoing clinical development of its lead candidate, ATYR1923, currently in a Phase 1b/2a clinical trial in patients with pulmonary sarcoidosis, as well as other initiatives, at the Cowen and Company 39th Annual Healthcare Conference, which is being held March 11...